Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ALI HEALTH
00241
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -269.70%-95.07M | ---- | -2.03%-25.72M | ---- | 47.20%-25.2M | ---- | -64.98%-47.73M | ---- | 69.85%-28.93M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 65.87%-314K | ---- | 15.98%-920K | ---- | 14.52%-1.1M | ---- | 51.59%-1.28M | ---- | 26.25%-2.65M |
| Impairment and provisions: | ---- | 26.06%34.98M | ---- | 2,565.80%27.75M | ---- | -93.01%1.04M | ---- | 1,729.12%14.89M | ---- | -97.63%814K |
| -Impairment of property, plant and equipment (reversal) | ---- | 73,500.00%736K | ---- | -92.31%1K | ---- | --13K | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 17.86%32.5M | ---- | 6,139.37%27.58M | ---- | -97.03%442K | ---- | 1,729.12%14.89M | ---- | -90.80%814K |
| -Other impairments and provisions | ---- | 914.53%1.75M | ---- | -70.65%172K | ---- | --586K | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | --40.83M | ---- | ---- | ---- | 26.67%-44K | ---- | -105.28%-60K | ---- | -52.49%1.14M |
| -Loss (gain) from sale of subsidiary company | ---- | --40.66M | ---- | ---- | ---- | ---41K | ---- | ---- | ---- | ---336K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | --167K | ---- | ---- | ---- | 95.00%-3K | ---- | -3,100.00%-60K | ---- | -99.92%2K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.47M |
| Depreciation and amortization: | ---- | -4.98%2.02M | ---- | -24.77%2.13M | ---- | -16.52%2.83M | ---- | -39.55%3.39M | ---- | -42.07%5.61M |
| Financial expense | ---- | -60.40%830K | ---- | -7.34%2.1M | ---- | -9.12%2.26M | ---- | 44.12%2.49M | ---- | 202.98%1.73M |
| Exchange Loss (gain) | ---- | 0.00%1K | ---- | -99.36%1K | ---- | 15,800.00%157K | ---- | -100.55%-1K | ---- | 369.23%183K |
| Special items | ---- | ---- | ---- | ---- | ---- | -100.18%-22K | ---- | 44.88%12.07M | ---- | 360.64%8.33M |
| Operating profit before the change of operating capital | ---- | -412.97%-16.72M | ---- | 126.61%5.34M | ---- | -23.68%-20.07M | ---- | -17.83%-16.23M | ---- | 72.86%-13.78M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -82.04%144K | ---- | 136.09%802K | ---- | -397.09%-2.22M | ---- | -698.21%-447K | ---- | -106.33%-56K |
| Accounts receivable (increase)decrease | ---- | 142.18%68.13M | ---- | -1,764.14%-161.51M | ---- | 146.79%9.71M | ---- | -268.84%-20.74M | ---- | -143.32%-5.62M |
| Accounts payable increase (decrease) | ---- | -161.10%-84.24M | ---- | 11,289.53%137.86M | ---- | -154.34%-1.23M | ---- | 146.03%2.27M | ---- | 49.91%-4.93M |
| prepayments (increase)decrease | ---- | 115.48%2.53M | ---- | -816.13%-16.35M | ---- | -108.28%-1.79M | ---- | 54.76%21.55M | ---- | -41.64%13.93M |
| Special items for working capital changes | ---- | -98.06%96K | ---- | 754.56%4.96M | ---- | -195.94%-757K | ---- | 626.00%789K | ---- | -70.45%-150K |
| Cash from business operations | ---- | -3.98%-30.05M | ---- | -76.62%-28.9M | ---- | -27.73%-16.37M | ---- | -20.82%-12.81M | ---- | 53.81%-10.6M |
| Other taxs | ---- | ---2.86M | ---- | ---- | ---- | 98.28%-33K | ---- | -644.57%-1.92M | ---- | -6,350.00%-258K |
| Special items of business | 24.56%-18.76M | ---- | -300.16%-24.87M | ---- | 19.15%-6.21M | ---- | 10.28%-7.69M | ---- | -64.94%-8.57M | ---- |
| Net cash from operations | 24.56%-18.76M | -13.88%-32.92M | -300.16%-24.87M | -76.27%-28.9M | 19.15%-6.21M | -11.30%-16.4M | 10.28%-7.69M | -35.64%-14.73M | -64.94%-8.57M | 52.70%-10.86M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 450.00%22K | ---- | 33.33%4K | ---- | -88.46%3K | ---- | -13.33%26K | ---- | 100.00%30K |
| Sale of fixed assets | ---- | --250K | ---- | ---- | ---- | -51.67%29K | ---- | 1,100.00%60K | ---- | -99.48%5K |
| Purchase of fixed assets | ---- | -10,900.00%-220K | ---- | 95.24%-2K | ---- | ---42K | ---- | ---- | ---- | -68.25%-106K |
| Sale of subsidiaries | ---- | --12K | ---- | ---- | ---- | ---31K | ---- | ---- | ---- | --336K |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4K | ---- | ---- |
| Other items in the investment business | -102.32%-6K | ---- | 26,000.00%259K | ---- | 92.86%-1K | ---- | -111.38%-14K | --5.77M | 547.37%123K | ---- |
| Net cash from investment operations | -102.32%-6K | 3,100.00%64K | 26,000.00%259K | 104.88%2K | 92.86%-1K | -100.70%-41K | -111.38%-14K | 2,107.92%5.85M | 547.37%123K | -70.72%265K |
| Net cash before financing | 23.74%-18.77M | -13.66%-32.85M | -295.93%-24.61M | -75.81%-28.9M | 19.29%-6.22M | -85.08%-16.44M | 8.81%-7.7M | 16.18%-8.88M | -63.17%-8.44M | 51.96%-10.6M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -94.85%837K |
| Refund | ---- | 98.07%-45K | ---- | -194.10%-2.33M | ---- | 61,925.00%2.47M | ---- | 99.27%-4K | ---- | 78.52%-551K |
| Issuing shares | ---- | -54.56%27.8M | ---- | 700.82%61.18M | ---- | -4.21%7.64M | ---- | -16.64%7.98M | ---- | -4.33%9.57M |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 36.61%-71K |
| Issuance expenses and redemption of securities expenses | ---- | 99.64%-9K | ---- | -782.81%-2.52M | ---- | -2,750.00%-285K | ---- | -233.33%-10K | ---- | ---3K |
| Other items of the financing business | -13.30%23.2M | ---- | 116.31%26.76M | ---- | 94.50%12.37M | ---- | -10.23%6.36M | ---- | 2,407.82%7.09M | ---- |
| Net cash from financing operations | -13.30%23.2M | -52.60%25.75M | 116.31%26.76M | 577.63%54.33M | 94.50%12.37M | 58.27%8.02M | -10.23%6.36M | -38.30%5.07M | 2,407.82%7.09M | -58.50%8.21M |
| Effect of rate | 600.90%556K | -195.45%-1.49M | 93.04%-111K | -390.29%-505K | -264.16%-1.6M | -412.12%-103K | 54.56%-438K | -95.74%33K | -138.07%-964K | 185.07%775K |
| Net Cash | 106.14%4.43M | -127.92%-7.1M | -65.05%2.15M | 401.98%25.43M | 559.33%6.16M | -120.68%-8.42M | 1.40%-1.34M | -59.93%-3.82M | 75.21%-1.36M | -5.06%-2.39M |
| Begining period cash | -31.66%18.54M | 1,088.44%27.13M | 1,088.44%27.13M | -78.87%2.28M | -78.87%2.28M | -25.93%10.81M | -23.83%10.81M | -9.94%14.59M | -12.43%14.19M | -16.42%16.2M |
| Cash at the end | -19.34%23.53M | -31.85%18.54M | 326.30%29.17M | 1,091.77%27.21M | -24.21%6.84M | -78.87%2.28M | -23.90%9.03M | -25.93%10.81M | -10.46%11.87M | -9.94%14.59M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | -19.34%23.53M | -31.66%18.54M | 326.30%29.17M | 1,088.44%27.13M | -24.21%6.84M | -78.87%2.28M | -23.90%9.03M | -25.93%10.81M | -10.46%11.87M | -9.94%14.59M |
| Cash and cash equivalent balance | -19.34%23.53M | -31.66%18.54M | 326.30%29.17M | 1,088.44%27.13M | -24.21%6.84M | -78.87%2.28M | -23.90%9.03M | -25.93%10.81M | -10.46%11.87M | -9.94%14.59M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.